[HTML][HTML] Global increase in breast cancer incidence: risk factors and preventive measures
Breast cancer is a global cause for concern owing to its high incidence around the world.
The alarming increase in breast cancer cases emphasizes the management of disease at …
The alarming increase in breast cancer cases emphasizes the management of disease at …
[HTML][HTML] A decade of clinical development of PARP inhibitors in perspective
Genomic instability is a hallmark of cancer, and often is the result of altered DNA repair
capacities in tumour cells. DNA damage repair defects are common in different cancer types; …
capacities in tumour cells. DNA damage repair defects are common in different cancer types; …
The American Association of Endocrine Surgeons guidelines for the definitive surgical management of thyroid disease in adults
KN Patel, L Yip, CC Lubitz, EG Grubbs, BS Miller… - Annals of …, 2020 - journals.lww.com
Objective: To develop evidence-based recommendations for safe, effective, and appropriate
thyroidectomy. Background: Surgical management of thyroid disease has evolved …
thyroidectomy. Background: Surgical management of thyroid disease has evolved …
Comparison of universal genetic testing vs guideline-directed targeted testing for patients with hereditary cancer syndrome
NJ Samadder, D Riegert-Johnson, L Boardman… - JAMA …, 2021 - jamanetwork.com
Importance Hereditary factors play a key role in the risk of developing several cancers.
Identification of a germline predisposition can have important implications for treatment …
Identification of a germline predisposition can have important implications for treatment …
NCCN guidelines insights: genetic/familial high-risk assessment: breast, ovarian, and pancreatic, version 1.2020: featured updates to the NCCN guidelines
MB Daly, R Pilarski, MB Yurgelun, MP Berry… - Journal of the National …, 2020 - jnccn.org
The NCCN Guidelines for Genetic/Familial High-Risk Assessment: Breast, Ovarian, and
Pancreatic provide recommendations for genetic testing and counseling for hereditary …
Pancreatic provide recommendations for genetic testing and counseling for hereditary …
[HTML][HTML] De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of …
G Curigliano, HJ Burstein, EP Winer, M Gnant… - Annals of …, 2017 - Elsevier
ABSTRACT The 15th St. Gallen International Breast Cancer Conference 2017 in Vienna,
Austria reviewed substantial new evidence on loco-regional and systemic therapies for early …
Austria reviewed substantial new evidence on loco-regional and systemic therapies for early …
[HTML][HTML] Genetic testing and results in a population-based cohort of breast cancer patients and ovarian cancer patients
AW Kurian, KC Ward, N Howlader… - Journal of Clinical …, 2019 - ncbi.nlm.nih.gov
PURPOSE Genetic testing for cancer risk has expanded rapidly. We examined clinical
genetic testing and results among population-based patients with breast and ovarian …
genetic testing and results among population-based patients with breast and ovarian …
Associations between cancer predisposition testing panel genes and breast cancer
Importance Germline pathogenic variants inBRCA1andBRCA2predispose to an increased
lifetime risk of breast cancer. However, the relevance of germline variants in other genes …
lifetime risk of breast cancer. However, the relevance of germline variants in other genes …
Consensus guidelines on genetictesting for hereditary breast cancer from the American Society of Breast Surgeons
ER Manahan, HM Kuerer, M Sebastian… - Annals of surgical …, 2019 - Springer
Background The purpose of this consensus guideline is to outline recommendations for
genetic testing that medical professionals can use to assess hereditary risk for breast …
genetic testing that medical professionals can use to assess hereditary risk for breast …
[HTML][HTML] Frequency of germline mutations in 25 cancer susceptibility genes in a sequential series of patients with breast cancer
Purpose Testing for germline mutations in BRCA1/2 is standard for select patients with
breast cancer to guide clinical management. Next-generation sequencing (NGS) allows …
breast cancer to guide clinical management. Next-generation sequencing (NGS) allows …